We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Worldwide Healthcare Trust plc (WWH) ORD GBP0.025

Sell:348.50p Buy:349.50p 0 Change: 1.50p (0.43%)
FTSE 250:0.41%
Market closed Prices as at close on 13 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:348.50p
Buy:349.50p
Change: 1.50p (0.43%)
Market closed Prices as at close on 13 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:348.50p
Buy:349.50p
Change: 1.50p (0.43%)
Market closed Prices as at close on 13 May 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

In order to achieve a high level of capital growth, the Company invests in the global healthcare sector and in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It uses gearing, and derivative transactions to mitigate risk and also to enhance returns.
Security Weight
Eli Lilly and Co 8.00%
Boston Scientific Corp 6.46%
AstraZeneca plc Ordinary US$0.25 5.92%
Intuitive Surgical Inc 5.85%
Novo Nordisk DKK0.1 B 5.76%
Biogen Inc 4.61%
Merck & Co Inc 4.14%
Daiichi Sankyo Co Ltd 3.72%
Tenet Healthcare Corp 3.16%
Stryker Corp 2.96%
Sector Weight
Healthcare 92.19%
Country Weight
United States 66.23%
United Kingdom 7.14%
Japan 6.24%
Denmark 5.76%
China 3.33%
France 2.73%
Hong Kong 0.73%
Netherlands 0.02%

Fee Structure

The Investment Manager receives a fee equal to 0.65% p.a. of the NAV of Company. The performance fee amounts to 15% of any outperformance of the NAV over the benchmark index. The Company may be terminated by either party giving notice of not less than 12 months.

Dividend Policy

It is the policy to pay out dividends to shareholders at least to the extent required to maintain investment trust status for each financial year. Such dividends will typically be paid twice a year by means of an interim dividend and a final dividend.

ASSET SPLIT

Total number of holdings: 59.

Trust Manager

Not currently available for this investment trust.

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Doug McCutcheonChairman, Humphrey van der Klugt, Sven Borho, Joanne Parfrey, Timothy Livett, Bandhana Rawal

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.